Staudt, Ross E Carlson, Robert D Snook, Adam E
Published in
Cancer biology & therapy
The immune system is capable of remarkably potent and specific efficacy against infectious diseases. For decades, investigators sought to leverage those characteristics to create immune-based therapies (immunotherapy) that might be far more effective and less toxic than conventional chemotherapy and radiation therapy for cancer. Those studies revea...
Chandran, Elias Figg, William D Madan, Ravi
Published in
Cancer biology & therapy
In the last decade, many life-prolonging therapeutic options have emerged for metastatic castration-resistant prostate cancer (mCRPC). The recent VISION trial is the first to demonstrate a survival benefit of Lutetium-177[177Lu]Lu-PSMA-617 in post-chemotherapy mCRPC. This journal club reviews the VISION trial in the context of the earlier TheraP tr...
Bajpai, Sagar Jin, Hong Ri Mucha, Bartosz Diehl, J Alan
Published in
Cancer biology & therapy
Overexpression of c-myc via increased transcription or decreased protein degradation is common to many cancer etiologies. c-myc protein degradation is mediated by ubiquitin-dependent degradation, and this ubiquitylation is regulated by several E3 ligases. The primary regulator is Fbxw7, which binds to a phospho-degron within c-myc. Here, we identif...
Han, Yadong Qian, Xu Xu, Teng Shi, Yang
Published in
Cancer biology & therapy
microRNA-331-3p (miR-331-3p) has been displayed as an oncogene in pancreatic cancer (PC). The current research set out to elucidate how miR-331-3p in carcinoma-associated fibroblasts (CAFs)-derived extracellular vesicles (EVs) facilitated the tumorigenesis in PC. First, a dual-luciferase reporter assay was adopted to investigate the relationship be...
Gao, Haoji Wang, Weige Li, Qinyu
Published in
Cancer biology & therapy
Glioma-associated oncogene (Gli) antagonist-61 (GANT61) not only suppresses the malignant behavior of several cancers but also presents synergistic effects with other anticancer agents on suppressing the progression of cancers, while relevant information is rare in anaplastic thyroid carcinoma (ATC). This study aimed to explore the therapeutic effe...
Hayat, Umar Elliott, Gary T Olszanski, Anthony J Altieri, Dario C
Published in
Cancer biology & therapy
Mitochondria are key tumor drivers, but their suitability as a therapeutic target is unknown. Here, we report on the preclinical characterization of Gamitrinib (GA mitochondrial matrix inhibitor), a first-in-class anticancer agent that couples the Heat Shock Protein-90 (Hsp90) inhibitor 17-allylamino-geldanamycin (17-AAG) to the mitochondrial-targe...
Yuan, Weidong Zhao, Hewei Zhou, Ang Wang, Shaochuang
Published in
Cancer biology & therapy
Hepatocellular carcinoma (HCC) is the most common type of liver cancer. Ephrin A4 (EFNA4) acts as an oncogene in multiple cancers but is little known in HCC. It is revealed that EFNA4 is highly expressed in patients with HCC and influences the proliferation of HCC cells; however, detailed regulatory mechanism of EFNA4 in HCC needs to be unveiled. H...
Lefler, Daniel S Tierno, Marni Brisson Bashir, Babar
Published in
Cancer biology & therapy
Cholangiocarcinoma is a highly morbid gastrointestinal malignancy for which available therapies are limited. Standard of care includes cytotoxic chemotherapies such as gemcitabine, platinum agents, nab-paclitaxel, and fluoropyrimidine analogues. However, tolerability of these regimens varies, and patients who do not tolerate chemotherapy have limit...
Zhou, Yuru Kong, Yunyuan Jiang, Mei Kuang, Linju Wan, Jinhua Liu, Shuyuan Zhang, Qian Yu, Kuai Li, Na Le, Aiping
...
Published in
Cancer biology & therapy
Curcumin, the primary bioactive component isolated from turmeric, has been found to possess a variety of biological functions, including anti-leukemia activity. However, the effect of curcumin in different leukemia cells vary. In this study, we demonstrated that curcumin induced the expression of AIM2, IFI16, and NLRC4 inflammasomes in leukemia cel...
Feng, Jinchun Li, Yan Zhu, Liping Zhao, Qian Li, Dan Li, Yuxiang Wu, Tao
Published in
Cancer biology & therapy
Radiotherapy plays important roles in the treatment of breast cancer (BC), which develops from malignant cells in the breast. Long non-coding RNAs (lncRNAs) have been reported to be implicated in radio-resistance or radio-sensitivity of human cancer, which includes breast cancer. Nevertheless, long intergenic non-protein coding RNA 0504 (LINC00504)...